Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Chronic Subdural Hematoma
NCT02362321Phase 4Terminated
- Sponsor
- CHU de Québec-Université Laval
- Start
- Jan 2007
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in chronic subdural hematoma (CSDH) (2 arms), sponsored by CHU de Québec-Université Laval. Primary endpoint: Rate of Need for Surgery Drainage at 6 months. Started Jan 2007; status: terminated.
02
Drugs
dexamethasone
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT02362321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362321.